April 15, 2022

FRONTEO Hosts Session Video Recording Event with Leading U.S. Law Firm Covington & Burling LLP

U.S.-based lawyers with extensive experience explain the latest litigation cases and trends for Japanese companies
February 15, 2022

FRONTEO Legal Link Portal hits 6,000 subscriber milestone

Fronteo hits 6,000 subscriber milestone thanks to variety of video lectures delivered by over one hundred highly acclaimed legal experts in Japan and the U.S.
February 7, 2022

Nishimura & Asahi and FRONTEO hold “Economic Security Initiative

Nishimura & Asahi and FRONTEO hold "Economic Security Initiative
November 2, 2021

FRONTEO Adopts Microsoft Azure to Improve Operational Efficiency in the Legal Tech AI Space in the U.S.

KIBIT Automator, an AI-based e-discovery and digital forensics platform, runs on Microsoft Azure, the world's most secure environment.
October 12, 2021

FRONTEO USA launched a new website on its Life Science business

FRONTEO USA launched a new website on its Life Science business, which is drawing attention. Under the title of “Equal Medical Care for Everybody with AI”, we introduce our AI system powered by “Concept Encoder”, the natural language analysis specialized in the Life Science fields below.
August 4, 2021

FRONTEO’s AI review tool “KIBIT Automator” is used for legal investigation and litigation cases in an US asset management company

NEW YORK, August 4, 2021 – FRONTEO (TSE: 2158) announced that our AI review tool "KIBIT Automator" was used for an investigative case of unauthorized access and removal of confidential information in the United States.
July 28, 2021

FRONTEO Korea built AI review tool “KIBIT Automator” on NAVER cloud

By building KIBIT Automator on a cloud environment, we will create a highly reliable service platform that meets a large amount of data processing demand, improve data analysis efficiency, and reduce man-hours and costs.
April 30, 2021

FRONTEO announces next-generation eDiscovery platform

Expanded the functions of the AI review tool “KIBIT Automator” which is a key to FRONTEO’s portfolio transformation, enabling one-stop handling of eDiscovery process from pre-processing to document review.
May 6, 2020

FRONTEO Has Identified 450 Candidate Compounds In Its Research On The Novel Coronavirus (COVID-19)

April 30, 2020

FRONTEO has Constructed a Pathway Map of the Coronavirus Infection (COVID-19) to be Published for Use in Therapeutic Drug Selection and Review